ArticleInternational journal of genomics2025
The Relationship Between Preoperative Neutrophil-Lymphocyte Ratio and Postoperative Length of Stay in Carotid Body Tumor Resection.
Article in International journal of genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Predictive value of preoperative neutrophil-to-lymphocyte ratio for prognosis in aortic dissection patients without hypertension following TEVAR.Frontiers in aging · 2026Article
- Integrating Preoperative NLR and PLR with Perioperative Clinical Factors: A Nomogram for Predicting Postoperative CRP Elevation After Laparoscopic Hysterectomy.International journal of women's health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Carotid body tumor (CBT) resection is a complex surgical procedure often resulting in extended postoperative length of stay (PLOS) due to potential nerve injuries, arterial damage, and wound complications. The neutrophil-to-lymphocyte ratio (NLR) is a known marker of systemic inflammation and has been associated with adverse outcomes in various surgical settings. However, the relationship between preoperative NLR and PLOS in CBT patients has not been explored. This study aims to investigate the association between preoperative NLR and PLOS in CBT resections, particularly examining whether elevated NLR correlates with longer hospital stays and potentially hinders recovery. In this retrospective cohort study, we analyzed data from 231 CBT patients who underwent resection at Changhai Hospital, Shanghai, between 2008 and 2020. Patients were grouped based on their PLOS (short, medium, and long stays), and NLR was calculated from peripheral blood samples taken preoperatively. Univariate and multivariate regression models adjusted for sociodemographic and operative factors, including Shamblin classification, were used to examine the relationship between NLR and PLOS. Elevated preoperative NLR has been found to be significantly correlated with prolonged PLOS, with each incremental increase in NLR corresponding to an approximate extension of 0.12 days in PLOS after adjusting for confounding factors. Stratified analysis revealed that this association was most pronounced in patients with Shamblin II tumors, likely due to the moderate tumor size and adhesion in these cases, which necessitates more extensive dissection and increases vulnerability to nerve injury. Elevated preoperative NLR may serve as a predictor of prolonged recovery in CBT resections, particularly for Shamblin II cases. This finding highlights the potential utility of NLR in preoperative assessment and patient management to optimize surgical timing and reduce hospital stays. Further research with larger cohorts is needed to confirm the predictive value of NLR and explore its clinical application in surgical planning for CBT patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.